	US 11,992,577 B2
	Adhesive for surgical staple line reinforcement
Loran Solorio, West Lafayette, IN (US); Steven Cohen, West Lafayette, IN (US); and Benjamin Patrick Kline, Lafayette, IN (US)
Assigned to Cook Biotech Incorporated, West Lafayette, IN (US)
Filed by Cook Biotech Incorporated, West Lafayette, IN (US)
Filed on Jul. 27, 2021, as Appl. No. 17/443,470.
Claims priority of provisional application 63/057,027, filed on Jul. 27, 2020.
Prior Publication US 2022/0023489 A1, Jan. 27, 2022
Int. Cl. A61L 24/10 (2006.01); A61L 24/00 (2006.01); C08L 1/28 (2006.01); C08L 5/08 (2006.01)

CPC A61L 24/102 (2013.01) [A61L 24/001 (2013.01); A61L 24/108 (2013.01); C08L 1/286 (2013.01); C08L 5/08 (2013.01); A61L 2300/414 (2013.01)]

14 Claims

1. A medical product, comprising:

a medical graft material; and

an adhesive on at least a portion of a surface of said medical graft material, wherein said adhesive comprises: chondroitin sulfate, carboxymethyl cellulose, sorbitol, and maltitol.